Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRA2C | P18825 | 7/20 | 0.66 |
| ▸ | ADRA2A | P08913 | 6/20 | 0.66 |
| ▸ | ADRA2B | P18089 | 6/20 | 0.66 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.66 |
| ▸ | LMNA | P02545 | 5/20 | 0.66 |
| ▸ | NISCH | Q9Y2I1 | 3/20 | 0.66 |
| ▸ | HTR1A | P08908 | 2/20 | 0.66 |
| ▸ | HRH2 | P25021 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | BLM | P54132 | 4/20 | 0.64 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.64 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.64 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.64 |
| ▸ | CFB | P00751 | 4/20 | 0.46 |
| ▸ | HTR1D | P28221 | 4/20 | 0.44 |
| ▸ | ADRA1D | P25100 | 4/20 | 0.44 |
| ▸ | ADRA1B | P35368 | 4/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2333058 | 0.85 | ADRA2C (0.76) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL29363838 | 0.80 | ADRA2C (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL8390103 | 0.80 | ADRA2C (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL49143 | 0.80 | ADRA2C (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL1321306 | 0.78 | BLM (1.00) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL1230620 | 0.77 | BLM (0.97) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL30484346 | 0.77 | BLM (0.97) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| SCHEMBL11252813 | 0.77 | ADRA2C (0.64) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| SCHEMBL11242767 | 0.76 | ADRA2C (0.74) | ADRA2CADRA2AADRA2BADRA1ALMNA | |
| Moxonidine SCHEMBL5006894 | 0.76 | ADRA2C (0.86) | ADRA2CADRA2AADRA2BADRA1ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150152114-A1 | PROCESS FOR THE PREPARATION OF AN INTERMEDIATE FOR A TRIAZOLOPYRIMIDINE CARBONUCLEOSIDE | ENANTIA, S.L. (ES) | 2015-06-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150152114-A1 | PROCESS FOR THE PREPARATION OF AN INTERMEDIATE FOR A TRIAZOLOPYRIMIDINE CARBONUCLEOSIDE | NUDT1, DUT, UMPS | ADRA2C 1943/4885ADRA2A 2831/4885ADRA2B 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.